Skip to content

Drug Metabolism and Personalized Therapy

ISSN 2363-8915

2 papers in the library · 6 citations · publishing 2017-2026

Papers

Sort Most recent Most cited

MDMA-induced CYP2D6 inhibition: concentration-dependent variability using dextromethorphan as a probe

Drug Metabolism and Personalized Therapy June 16, 2026 Faezeh Ahmadi, Hoda Lavasani, Mohammadhosein Keshvadi et al.

OBJECTIVES: Ecstasy is commonly abused due to entactogenic effects. Although our previous studies on isolated perfused rat model confirmed inhibition of CYP2D6 by MDMA, the time for enzyme recovery was different when mirtazapine and tramadol were used as substrates. Therefore, present study intended to investigate CYP2D6 inhibition by MDMA using dextromethorphan as a well-known probe. Two...

Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats

Drug Metabolism and Personalized Therapy January 26, 2017 Bardia Jamali, Behjat Sheikholeslami, Yalda Hosseinzadeh Ardakani et al. 6 citations

AbstractBackground:Tramadol is prone to be abused alone, or in combination with 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy). It was reported that 95% of people with a history of substance abuse in the United States used tramadol in 2004. According to the WHO report in 2016, there was a growing number of tramadol abusers alone or in combination with psychoactive substances such as MDMA in...